Literature DB >> 19746446

The mammalian anti-proliferative BTG/Tob protein family.

G Sebastiaan Winkler1.   

Abstract

The mammalian BTG/Tob family comprises six proteins (BTG1, BTG2/PC3/Tis21, BTG3/ANA, BTG4/PC3B, Tob1/Tob and Tob2), which regulate cell cycle progression in a variety of cell types. They are characterised by the conserved N-terminal domain spanning 104-106 amino acids. Recent biochemical and structural data indicate that the conserved BTG domain is a protein-protein interaction module, which is capable of binding to DNA-binding transcription factors as well as the paralogues CNOT7 (human Caf1/Caf1a) and CNOT8 (human Pop2/Calif/Caf1b), two deadenylase subunits of the Ccr4-Not complex. Consistent with this finding, several members of the BTG/Tob family are shown to be implicated in transcription in the nucleus and cytoplasmic mRNA deadenylation and turnover. The C-terminal regions are less conserved and appear to mediate protein-protein interactions that are unique to each family member. The human and mouse BTG/Tob proteins will be the focus of this review and structural aspects of BTG/Tob interactions with components of the Ccr4-Not complex, and the role of the BTG/Tob proteins in the regulation of gene expression, tumourigenesis and cancer will be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19746446     DOI: 10.1002/jcp.21919

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  129 in total

1.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.

Authors:  Jens G Lohr; Petar Stojanov; Michael S Lawrence; Daniel Auclair; Bjoern Chapuy; Carrie Sougnez; Peter Cruz-Gordillo; Birgit Knoechel; Yan W Asmann; Susan L Slager; Anne J Novak; Ahmet Dogan; Stephen M Ansell; Brian K Link; Lihua Zou; Joshua Gould; Gordon Saksena; Nicolas Stransky; Claudia Rangel-Escareño; Juan Carlos Fernandez-Lopez; Alfredo Hidalgo-Miranda; Jorge Melendez-Zajgla; Enrique Hernández-Lemus; Angela Schwarz-Cruz y Celis; Ivan Imaz-Rosshandler; Akinyemi I Ojesina; Joonil Jung; Chandra S Pedamallu; Eric S Lander; Thomas M Habermann; James R Cerhan; Margaret A Shipp; Gad Getz; Todd R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

2.  Molecular characterization, expression pattern and association analysis of the porcine BTG2 gene.

Authors:  X Y Mo; J Lan; Q Z Jiao; Y Z Xiong; B Zuo; F E Li; D Q Xu; M G Lei
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

3.  SETD1A induced miRNA network suppresses the p53 gene expression module.

Authors:  Toshifumi Yae; Ken Tajima; Shyamala Maheswaran
Journal:  Cell Cycle       Date:  2016-02-11       Impact factor: 4.534

4.  Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.

Authors:  Inna Lipchina; Yechiel Elkabetz; Markus Hafner; Robert Sheridan; Aleksandra Mihailovic; Thomas Tuschl; Chris Sander; Lorenz Studer; Doron Betel
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

5.  Identification of BTG1 Status in Solid Cancer for Future Researches Using a System Review and Meta-analysis.

Authors:  Xiu-Qiong Chen; Fan-Qiao Meng; Hua Xiong; Ya-Li Wang; Wen-Hua Tang; Yan-Mei Zou
Journal:  Curr Med Sci       Date:  2020-03-13

6.  Transducer of erbB2.1 is a potential cellular target of gefitinib in lung cancer therapy.

Authors:  Ke-Kang Sun; Yang Yang; Lin Zhao; Li-Li Wang; Yang Jiao
Journal:  Oncol Lett       Date:  2012-10-15       Impact factor: 2.967

7.  Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1.

Authors:  Yu-Che Cheng; Tsong-Yu Lin; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

8.  Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

Authors:  Emanuela Leone; Eugenio Morelli; Maria T Di Martino; Nicola Amodio; Umberto Foresta; Annamaria Gullà; Marco Rossi; Antonino Neri; Antonio Giordano; Nikhil C Munshi; Kenneth C Anderson; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

9.  Coxsackie and adenovirus receptor is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemia.

Authors:  Roos F J Marsman; Connie R Bezzina; Fabian Freiberg; Arie O Verkerk; Michiel E Adriaens; Svitlana Podliesna; Chen Chen; Bettina Purfürst; Bastian Spallek; Tamara T Koopmann; Istvan Baczko; Cristobal G Dos Remedios; Alfred L George; Nanette H Bishopric; Elisabeth M Lodder; Jacques M T de Bakker; Robert Fischer; Ruben Coronel; Arthur A M Wilde; Michael Gotthardt; Carol Ann Remme
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

10.  Tob2 inhibits peroxisome proliferator-activated receptor γ2 expression by sequestering Smads and C/EBPα during adipocyte differentiation.

Authors:  Akinori Takahashi; Masahiro Morita; Kazumasa Yokoyama; Toru Suzuki; Tadashi Yamamoto
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.